Ads
related to: alzheimer's patient perspectives journal list of drugs treatment management- Alzheimer's Disease Info
Learn About the Stages of AD &
Diagnostic Tests for Patients.
- Getting Started
Read Infusion FAQs & Tips For
Getting Started With Treatment.
- For Care Partners
Help Support Your Loved One. See
Helpful Tips & Resources.
- Support & Resources
Access Downloadable Patient
Resources Available On-Site.
- Alzheimer's Disease Info
Search results
Results From The WOW.Com Content Network
The American Journal of Alzheimer's Disease & Other Dementias is abstracted and indexed in, among other databases: SCOPUS, and the Social Sciences Citation Index. According to the Journal Citation Reports, its 2010 impact factor is 1.774, ranking it 104 out of 185 journals in the category 'Clinical Neurology'.
Medical journals are published regularly to communicate new research to clinicians, medical scientists, and other healthcare workers. This article lists academic journals that focus on the practice of medicine or any medical specialty. Journals are listed alphabetically by journal name, and also grouped by the subfield of medicine they focus on.
One of the common diseases being studied in neuroscience is Alzheimer's disease. Many studies have been done to show how nanoparticles can be used as a platform to deliver therapeutic drugs to these patients with the disease. A few Alzheimer's drugs that have been studied especially are rivastigmine, tacrine, quinoline, piperine, and curcumin. [2]
People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's disease, new evidence shows. Semaglutide drugs may help keep Alzheimer's at bay
Rivastigmine, sold under the brand name Exelon among others, is an acetylcholinesterase inhibitor used for the treatment of dementia associated with Alzheimer's disease and with Parkinson's disease. [ 4 ] [ 6 ] [ 7 ] Rivastigmine can be administered orally or via a transdermal patch ; the latter form reduces the prevalence of side effects, [ 8 ...
Lecanemab may cause amyloid-related imaging abnormalities (ARIA). ARIA is often asymptomatic, but serious and life-threatening events rarely may occur.ARIA most commonly presents as temporary swelling of the brain that usually resolves over time and may be accompanied by small spots of bleeding in or on the surface of the brain, though some people may have symptoms such as headache, confusion ...
Ads
related to: alzheimer's patient perspectives journal list of drugs treatment management